DIRS.INFO The most relevant business & tech news

REUTERS/Rupam Jain/File PhotoGURUGRAM, India, Aug 10 (Reuters) - Over 3,000 poor Muslims have fled a business hub outside New Delhi this month, fearing for their lives after Hindu-Muslim clashes and sporadic attacks targeting them, residents, police and a community group said. The Gurugram president of Jamiat-Ulema-e-Hind (Council of Indian Muslim Theologians) Mufti Mohammed Salim estimated that more than 3,000 Muslims had left the district after the violence. "Many Muslims decided it's best to leave for a while," said Sheikh, adding that some Hindu owners of shops rented out to Muslims wanted them to vacate. "No one is asking them to leave and we are providing full security in all communally sensitive areas," he told Reuters. Reporting by Rupam Jain and Sakshi Dayal; Editing by YP Rajesh and Angus MacSwanOur Standards: The Thomson Reuters Trust Principles.

Persons: Rupam, Raufullah Javed, Mufti Mohammed Salim, Shahid Sheikh, it's, Narendra Modi's, Ernst &, Anil Vij, Rupam Jain, Sakshi Dayal, YP Rajesh, Angus MacSwan Organizations: REUTERS, Reuters, Bharatiya Janata Party, BJP, Police, Fortune, American Express, Dell, Samsung, Ernst, Ernst & Young, Deloitte, YP, Thomson Locations: Gurugram, New Delhi, India, Nuh, Haryana, Bihar, Tigra, India's, Gurgaon

☆ Hindu-Muslim riots expose risk at major Indian business hub
▼ + stars: | 2023-08-03 | by ( Rupam Jain | ) www.reuters.com time to read: +4 min

Seven people were killed and over 70 injured in rioting in Nuh and Gurugram districts of Haryana state after a Hindu religious procession was targeted and a mosque attacked in retaliation. Gurugram, formerly known as Gurgaon, is a city of over 1.5 million people that shares a border with New Delhi. "Muslim men attacked the Hindu procession and killed many of our people," said Praveen Babbar, a leader of Hindu Yuva Vahini (Hindu Youth Force). Haryana Police, however, said they acted swiftly and prevented riots from spreading, and that two of its men were killed in the violence. Reporting by Rupam Jain, Additional reporting by Sakshi Dayal; Editing by YP Rajesh and Raju GopalakrishnanOur Standards: The Thomson Reuters Trust Principles.

Persons: Adnan Abidi, Anil Vij, Vij, Ernst &, Gurugram, Narendra Modi's, Praveen Babbar, Aftab Ahmed, Tara Kartha, Rupam Jain, Sakshi Dayal, YP Rajesh, Raju Gopalakrishnan Organizations: REUTERS, Bharatiya Janata Party, BJP, nab, Reuters, Fortune, American Express, Dell, Samsung, Ernst, Ernst & Young, Deloitte, Hindu, Force, Haryana Police, Analysts, of Peace, YP, Thomson Locations: Nuh district, Haryana, India, Delhi, Nuh, Gurugram, Gurgaon, New Delhi, Suzuki's, India's, Nuh's

The Additional Chief Secretary, G. Anupama, said in a text message, "Enquiry is underway" and directed Reuters to the health minister for Haryana state, Anil Vij, for further details. Its chief minister and health minister, to whom Yashpal also sent his complaint, did not respond to requests for comment. Naresh Kumar Goyal, the founder of Maiden Pharmaceuticals, told Reuters in December his company did nothing wrong in the production of the cough syrup. The bribery allegation was one of about half a dozen claims of corruption by Yashpal against Taneja in the letter. Yashpal told Reuters he did not comply, because he did not feel comfortable bringing such details to the deputy of someone he had accused of corruption.

Persons: Sagnia, Edward McAllister, Yashpal, Manmohan Taneja, Taneja, Maiden, Yashpal –, –, Shatrujeet Kapur, Kapur, Anupama, Anil Vij, Vij, Naresh Kumar Goyal, Goyal, Narendra Modi, Taneja's, Lalit Kumar Goel, Goel, Krishna N, Jennifer Rigby, Sara Ledwith, Michele Gershberg Organizations: REUTERS, World Health Organization, WHO, Reuters, Corruption Bureau, Maiden Pharmaceuticals, pharma, Corruption, Taneja, EG, Thomson Locations: Yundum, Gambia, DELHI, Haryana, New Delhi, Vietnam, India, London

☆ India halts cough syrup production at factory linked to Gambia deaths
▼ + stars: | 2022-10-12 | by ( ) www.reuters.com time to read: +3 min

NEW DELHI, Oct 12 (Reuters) - Indian authorities have halted production of cough syrup at a factory of Maiden Pharmaceuticals, a state minister said on Wednesday, after a WHO report that the medicine may be linked to the deaths of dozens of children in Gambia. The WHO said last week that laboratory analysis of four Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - had "unacceptable" amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury. He told Reuters last week that the company was trying to find out from its buyer what had happened in Gambia. Maiden says on its web site it has an annual production capacity of 2.2 million syrup bottles, 600 million capsules, 18 million injections, 300,000 ointment tubes and 1.2 billion tablets at three factories. The cough syrups had been approved for export only to Gambia, India says, although the WHO says they may have gone elsewhere through informal markets.

Search resuls for: "Anil Vij"

4 mentions found